NuvaRing has been associated with venous thromboembolic (VTE) events such as pulmonary embolism (PE) and deep vein thrombosis (DVT) as well as ischemic stroke (CVA) and myocardial infarction (MI), or heart attack.
Like OrthoEvra, NuvaRing has shown to cause serious adverse health risks for consumers of the product. This vaginal ring contains a relatively high dose of etonogestrel.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.